DAVID STEINFELD: Open Payments
NPI 1043790611 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 32 payments from 9 companies in 2025. Trend: 2023 $247 · 2024 $309 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $205 |
| Otsuka America Pharmaceutical, Inc. | 6 | $103 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, Jornay PM, SPRAVATO, INGREZZA, CAPLYTA, ARISTADA, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
